Pharmaceutical Manufacturing News and Research

RSS

Cherwell selected for quality and service in environmental monitoring by Portsmouth PMU

Cherwell Laboratories, specialists in cleanroom microbiology solutions for the pharmaceutical and related industries, has been assisting Portsmouth Pharmaceutical Manufacturing Unit (PMU) in their extensive environmental monitoring (EM) programme for over 20 years

From Cherwell Laboratories 18 Nov 2015

LSTM's health economists sketch out the importance for universal access to medicines

LSTM's health economists Professor Louis Niessen and Dr Jahangir Khan outline the importance for universal access to medicines in the control of neglected diseases, other major infections, and chronic diseases.

22 Oct 2015

Study reveals poor levels of use, availability and affordability of cardiovascular disease medicines worldwide

New research published in The Lancet shows that the use of vital life-saving generic (and supposedly inexpensive) medicines for prevention in people with existing heart disease is poor worldwide. In low-income and middle-income countries these medicines are not widely available and, when available, can often be unaffordable. In rich countries, although such medicines are both available and affordable, 35% to 50% of patients who have heart disease or a previous stroke still do not receive them.

22 Oct 2015

Rutgers-led research consortium receives NIH grant to support continuous manufacturing systems for pharmaceuticals

The U.S. Food and Drug Administration (FDA) has awarded $4.9 million in grant funding to institutions in a research consortium based at the Rutgers University School of Engineering to support the introduction of continuous manufacturing techniques for pharmaceuticals.

16 Oct 2015

New manganese-based catalyst may accelerate drug discovery, development

Chemists have long believed that inserting nitrogen -- a beneficial ingredient for making many pharmaceuticals and other biologically active molecules -- into a carbon-hydrogen bond requires a trade-off between catalyst reactivity and selectivity.

15 Oct 2015

Academies and DFG point out limitations and risks of new genome editing techniques

More efficient bacteria and yeasts for use in fuel and drug production, new strategies to combat antibiotic-resistant germs, and innovative plant breeding methods - new molecular biology techniques that permit targeted genetic modification are giving rise to many promising new opportunities in research and application.

29 Sep 2015

Novel device to mass produce Lidocaine

One of the world’s most in-demand anaesthetics can now be produced on the spot, thanks to the thermos-flask sized device that recently won Flinders University inventor Professor Colin Raston an Ig Nobel prize.

28 Sep 2015

Innovative detector could expand use of polarized light for drug screening, surveillance

Invention of the first integrated circularly polarized light detector on a silicon chip opens the door for development of small, portable sensors that could expand the use of polarized light for drug screening, surveillance, optical communications and quantum computing, among other potential applications.

23 Sep 2015

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Hospira today announced that Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered in Australia. This registration paves the way for the Federal Government to reduce the cost of some of the most expensive medicines on the Pharmaceutical Benefits Scheme (PBS).

20 Aug 2015

NanoViricides speeds up HerpeCide drug development program

NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, reports that it is accelerating its HerpeCide drug development program.

17 Aug 2015

CPhI reports positive outlook on the Chinese pharmaceutical market

CPhI – a division of UBM EMEA – alongside UBM Sinexpo, announces the findings of the Pharma Insights China 2015 report.

13 Aug 2015

New review points to most promising areas for liposomes' further development

An international group of scientists, including Vladimir Chupin, head of the Biophysics Section at MIPT, and Vladimir Torchilin (Northeastern University, the USA), one of the world's leading experts in pharmacology, recently presented a review of liposomes, microscopic capsules widely used all over the world in the development of new drugs.

11 Aug 2015

Biontech, Siemens enter into strategic collaboration on manufacture of personalized cancer vaccines

Siemens and BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, have entered into a strategic collaboration.

25 Jun 2015

Florida State Board of Pharmacy approves Unique Pharmaceuticals' license for sterile distribution

UNIQUE PHARMACEUTICALS, a 503B current Good Manufacturing Practices (CGMP) Outsourcing Facility, today announced its licensure approval in Florida. The Florida State Board of Pharmacy review committee approved Unique Pharmaceuticals' license June 10 for distribution of sterile and non-sterile compounded medications.

23 Jun 2015

OSU microbiologists discover new type of dairy or food thickener with probiotic characteristics

Microbiologists at Oregon State University have discovered and helped patent and commercialize a new type of dairy or food thickener, which may add probiotic characteristics to the products in which it's used.

10 Jun 2015

CPhI Istanbul 2015 opens as Turkey continues to dominate the MENA pharma region

Turkey is fast emerging as a new hub for pharma manufacturing. This year, CPhI Istanbul will welcome more than 200 exhibitors from 23 Countries and over 4,000 visitors..

12 May 2015

ChemRar, Lancet partner to develop and commercialize new medicines in Russia

ChemRar High Tech Center, the Russian pharmaceutical investment and R&D group, and Lancet, Russian Distribution Company, have announced collaboration for research, development and commercialization of new medicines in Russia with the intention to stimulate the innovative development of the Russian pharmaceutical industry.

16 Apr 2015

Helsinn's Swiss manufacturing subsidiary bags 2015 CMO Leadership Award

Helsinn, the Swiss Group focused on building quality cancer care, is pleased to announce that its Swiss manufacturing subsidiary, Helsinn Advanced Synthesis SA, has won a 2015 CMO Leadership Award, determined by contract manufacturing client research.

2 Apr 2015

Bioquell QUBE to be showcased at EAHP 2015

The latest generation isolator, the Bioquell QUBE, will be showcased on stand 117 at the European Association of Hospital Pharmacists 20th annual conference in Hamburg, 25th to 27th March 2015.

26 Mar 2015

Theravectys gets authorization to produce lentiviral vectors for clinical use and CAR-T cell-based immunotherapy

THERAVECTYS, a clinical development biotechnology company that focuses on the development of therapeutic vaccines and immunotherapies, proudly announces that its manufacturing plant has obtained the status of a pharmaceutical manufacturing establishment, granted by the French National Agency for Medicines and Health Products Safety.